ArticleCells2024

Intravenous MSC-Treatment Improves Impaired Brain Functions in the R6/2 Mouse Model of Huntington's Disease via Recovered Hepatic Pathological Changes.

Libo Yu-Taeger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.